Proteinase-3 antineutrophil cytoplasm antibody positivity in patients without primary systemic vasculitis

Journal of Clinical Rheumatology

Volumn 18, Issue 7, 2012, Pages 336-340

  McAdoo, Stephen Paul ^a   Hall, Angela ^b   Levy, Jeremy ^a   Salama, Alan D ^c   Pusey, Charles D ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

ANCA associated vasculitis (AAV); antineutrophil cytoplasm antibody (ANCA); enzyme linked immunosorbent assay (ELISA); Luminex; vasculitis

Indexed keywords

MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; HUMAN; IMMUNOFLUORESCENCE; INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOIMMUNE DISEASES; HUMANS; INCIDENTAL FINDINGS; INFECTION; MIDDLE AGED; MYELOBLASTIN; NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84867768049     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31826d2005     Document Type: Article

References (37)

1. Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int. 1998;53:743-753. (Pubitemid 28124291)
2. Savige J, Gillis D, Benson E, et al. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol. 1999;111:507-513. (Pubitemid 29153147)
3. Savige J, Dimech W, Fritzler M, et al. Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol. 2003;120:312-318. (Pubitemid 37295101)
4. Zuckerman KK, Leventhal L, Wynne C. Positive C-ANCA in a patient with lymphoma and without vasculitis. J Clin Rheumatol. 1997;3:279-281. (Pubitemid 27451303)
5. Davenport A. "False positive" perinuclear and cytoplasmic anti-neutrophil cytoplasmic antibody results leading to misdiagnosis of Wegener's granulomatosis and/or microscopic polyarteritis. Clin Nephrol. 1992;37:124-130.
6. Chirinos JA, Corrales-Medina VF, Garcia S, et al. Endocarditis associated with antineutrophil cytoplasmic antibodies: a case report and review of the literature. Clin Rheumatol. 2007;26:590-595. (Pubitemid 46359307)
7. McAdoo SP, Densem C, Salama A, et al. Bacterial endocarditis associated with proteinase 3 anti-neutrophil cytoplasm antibody. NDT Plus. 2011;4:208-210.
8. Flores-Suarez LF, Cabiedes J, Villa AR, et al. Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis. Rheumatology (Oxford). 2003;42:223-229. (Pubitemid 36305606)
9. Teixeira L, Mahr A, Jaureguy F, et al. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis. Rheumatology (Oxford). 2005;44:247-250. (Pubitemid 40277412)
10. Esquivel-Valerio JA, Flores-Suarez LF, Rodriguez-Amado J, et al. Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation. Clin Exp Rheumatol. 2010;28(1 suppl 57):35-39.
11. Cornely OA, Hauschild S, Weise C, et al. Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infection. Infection. 1999;27:92-96. (Pubitemid 29142161)
12. Savige JA, Chang L, Horn S, et al. Anti-nuclear, anti-neutrophil cytoplasmic and antiYglomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity. 1994;18:205-211. (Pubitemid 24344809)
13. Pudifin DJ, Duursma J, Gathiram V, et al. Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody. Clin Exp Immunol. 1994;97:48-51. (Pubitemid 24244054)
14. Constantin A, Marin F, Oksman F, et al. Antineutrophil cytoplasmic antibodies in leptospirosis. J Rheumatol. 1996;23:411.
15. Chou TN, Hsu TC, Chen RM, et al. Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL). Lupus. 2000;9:551-554.
16. Wu YY, Hsu TC, Chen TY, et al. Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection. Clin Exp Immunol. 2002;128:347-352.
17. Pradhan V, Badakere SS, Shankarkumar U, et al. Anti-neutrophil cytoplasmic antibodies (ANCA) in malaria. Indian J Malariol. 2002;39:51-59. (Pubitemid 37492852)
18. Tervaert JW, Popa ER, Bos NA. The role of superantigens in vasculitis. Curr Opin Rheumatol. 1999;11:24-33. (Pubitemid 29057577)
19. Pendergraft WF 3rd, Preston GA, Shah RR, et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med. 2004;10:72-79. (Pubitemid 38524701)
20. Kain R, Exner M, Brandes R, et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med. 2008;14:1088-1096.
21. Rao JK, Weinberger M, Oddone EZ, et al. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med. 1995;123:925-932.
22. Arnold DF, Timms A, Luqmani R, et al. Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients. J Clin Pathol. 2010;63:678-680.
23. Cui Z, Zhao MH, Segelmark M, et al. Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. Kidney Int. 2010;78:590-597.
24. Hellmich B, Csernok E, Fredenhagen G, et al. A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3. Clin Exp Rheumatol. 2007;25(1 suppl 44):S1YS5. (Pubitemid 46656585)
25. Roggenbuck D, Buettner T, Hoffmann L, et al. High-sensitivity detection of autoantibodies against proteinase-3 by a novel third-generation enzyme-linked immunosorbent assay. Ann N Y Acad Sci. 2009;1173:41-46.
26. Rutgers A, Damoiseaux J, Roozendaal C, et al. ANCA-GBM dot-blot: evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis. J Clin Immunol. 2004;24:435-440. (Pubitemid 39005576)
27. Damoiseaux J, Vaessen M, Knapen Y, et al. Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease. Ann N Y Acad Sci. 2007;1109:454-463. (Pubitemid 47511388)
28. Trevisin M, Pollock W, Dimech W, et al. Evaluation of a multiplex flow cytometric immunoassay to detect PR3-and MPO-ANCA in active and treated vasculitis, and in inflammatory bowel disease (IBD). J Immunol Methods. 2008;336:104-112.
29. Maillefert JF, Pfitzenmeyer P, Thenet M, et al. Prevalence of ANCA in a hospitalized elderly French population. Clin Exp Rheumatol. 1997;15:603-607. (Pubitemid 27501645)
30. Shapira Y, Poratkatz BS, Gilburd B, et al. Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults. Clin Rev Allergy Immunol. 2012;42:154-163.
31. Owshalimpur D, Arbogast CB, Olson SW. Serum anti-neutrophil cytoplasmic autoantibodies prior to the clinical presentation of Wegener's granulomatosis (ASN Renal Week Abstract F-P01290). 2009.
32. Olson SW, Arbogast CB, Baker TP, et al. Asymptomatic autoantibodies associate with future antiYglomerular basement membrane disease. J Am Soc Nephrol. 2011;22:1946-1952.
33. Jennette JC, Falk RJ, Gasim AH. Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis. Curr Opin Nephrol Hypertens. 2011;20:263-270.
34. McAdoo SP, Tam FW, Pusey CD. Disease models of rapidly progressive glomerulonephritis. Drug Discov Today. 2010;7:43-50.
35. Wiik A. Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases. Autoimmun Rev. 2002;1:67-72. (Pubitemid 38367428)
36. Jayne DR, Weetman AP, Lockwood CM. IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol. 1991;84:476-481.
37. Xu PC, Cui Z, Chen M, et al. Comparison of characteristics of natural autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from patients with microscopic polyangiitis. Rheumatology (Oxford). 2011;50:1236-1243.